Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-27

Clinical Trial Update: Exenatide for Treating Cocaine Use Disorder [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating exenatide for cocaine use disorder has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Cocaine Use Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-06-27